These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11770168)

  • 21. Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis.
    Psaty BM; Furberg CD; Ray WA; Weiss NS
    JAMA; 2004 Dec; 292(21):2622-31. PubMed ID: 15572720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cerivastatin withdrawal crisis: a "post-mortem" analysis.
    Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P
    Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cerivastatin and acute kidney failure caused by rhabdomyolysis].
    Bravo JJ; Novoa D; Romero R; Sánchez-Guisande D
    Nefrologia; 2001; 21(5):509. PubMed ID: 11795023
    [No Abstract]   [Full Text] [Related]  

  • 24. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH; Davidson MH
    Am J Cardiol; 2005 Jan; 95(1):120-2. PubMed ID: 15619408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayer faces potential fine over cholesterol lowering drug.
    Tuffs A
    BMJ; 2001 Aug; 323(7310):415. PubMed ID: 11520825
    [No Abstract]   [Full Text] [Related]  

  • 26. Statin safety.
    Foxton J
    Nurs Stand; 2001 Sep 19-25; 16(1):20. PubMed ID: 11977679
    [No Abstract]   [Full Text] [Related]  

  • 27. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
    Backman JT; Kyrklund C; Neuvonen M; Neuvonen PJ
    Clin Pharmacol Ther; 2002 Dec; 72(6):685-91. PubMed ID: 12496749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the synergistic adverse effects of concomitant therapy with statins and fibrates on rhabdomyolysis.
    Matzno S; Tazuya-Murayama K; Tanaka H; Yasuda S; Mishima M; Uchida T; Nakabayashi T; Matsuyama K
    J Pharm Pharmacol; 2003 Jun; 55(6):795-802. PubMed ID: 12841940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myotoxicity and rhabdomyolisis due to statins].
    Banga JD
    Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-associated rhabdomyolysis.
    Ardati A; Stolley P; Knapp DE; Wolfe SM; Lurie P
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):287. PubMed ID: 15782398
    [No Abstract]   [Full Text] [Related]  

  • 31. High rates of adverse effects and patient unawareness of withdrawn lipid-lowering drug combination in a public hospital clinic.
    Schiff GD; Keehr LM; Sai TT; Bult J
    Pharmacoepidemiol Drug Saf; 2002 Dec; 11(8):643-5. PubMed ID: 12512238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerivastatin withdrawn from market.
    Thompson CA
    Am J Health Syst Pharm; 2001 Sep; 58(18):1685. PubMed ID: 11571807
    [No Abstract]   [Full Text] [Related]  

  • 33. [After recall of cerivastatin. How safe are statins in reality? (interview by Dr. Dirk Einecke)].
    Schwandt P
    MMW Fortschr Med; 2001 Aug; 143(33-34):12. PubMed ID: 11561452
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
    Sparing R; Sellhaus B; Noth J; Block F
    Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fatal rhabdomyolysis caused by cerivastatin].
    Scheen AJ
    Rev Med Liege; 2001 Aug; 56(8):592-4. PubMed ID: 11584446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayer to settle lawsuits over Baycol.
    Health News; 2004 Sep; 10(9):2. PubMed ID: 15597437
    [No Abstract]   [Full Text] [Related]  

  • 37. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
    Jamal SM; Eisenberg MJ; Christopoulos S
    Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How a statin might destroy a drug company.
    Lancet; 2003 Mar; 361(9360):793. PubMed ID: 12642039
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerivastatin-induced rhabdomyolysis: 11 case reports.
    Ravnan SL; Locke C; Yee WP; Haase K
    Pharmacotherapy; 2002 Apr; 22(4):533-7. PubMed ID: 11939690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cerivastatin and the PRINCESS study: reflexions after 1 year].
    Manfredi C; Macrì R; Bartoli M
    Ital Heart J Suppl; 2003 Feb; 4(2):125-7. PubMed ID: 12762262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.